Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors

Int J Cardiol. 2015 Apr 1:184:428-430. doi: 10.1016/j.ijcard.2015.02.077. Epub 2015 Feb 24.
No abstract available

Keywords: Acute coronary syndromes; Chronic kidney disease; Keywords; P2Y12 blockers; Platelet reactivity.

Publication types

  • Letter

MeSH terms

  • Acute Coronary Syndrome* / blood
  • Acute Coronary Syndrome* / complications
  • Acute Coronary Syndrome* / drug therapy
  • Adenosine / administration & dosage
  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacokinetics
  • Adenosine / pharmacology
  • Aged
  • Drug Monitoring / methods
  • Female
  • Humans
  • Kidney Function Tests / methods
  • Male
  • Middle Aged
  • Platelet Aggregation / drug effects*
  • Platelet Function Tests / methods
  • Prasugrel Hydrochloride* / administration & dosage
  • Prasugrel Hydrochloride* / pharmacokinetics
  • Purinergic P2Y Receptor Antagonists / administration & dosage
  • Purinergic P2Y Receptor Antagonists / pharmacokinetics
  • Renal Insufficiency, Chronic* / blood
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / physiopathology
  • Statistics as Topic
  • Ticagrelor
  • Treatment Outcome

Substances

  • Purinergic P2Y Receptor Antagonists
  • Prasugrel Hydrochloride
  • Ticagrelor
  • Adenosine